Methylxanthine [EPC]

Methylxanthine [EPC] was reported 58114 times

Drugs of the Methylxanthine [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 AMYLOID ARTHROPATHY 65 0.9286
1 RIGHT ATRIAL HYPERTROPHY 89 0.8091
2 HEART SOUNDS 62 0.6458
3 GRIP STRENGTH 139 0.6070
4 ANTACID THERAPY 49 0.3769
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 752 0.3754
6 BRONCHIAL NEOPLASM 46 0.3382
7 C-REACTIVE PROTEIN 296 0.3193
8 SWOLLEN JOINT COUNT 78 0.3120
9 LUPUS VULGARIS 387 0.3071
10 SLEEP DISORDER THERAPY 57 0.2879
11 MEDICATION OVERUSE HEADACHE 236 0.2757
12 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 162 0.2425
13 PROLONGED EXPIRATION 62 0.2366
14 SWOLLEN JOINT COUNT INCREASED 672 0.2105
15 ANALGESIC THERAPY 66 0.2056
16 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 399 0.1924
17 APPENDICOLITH 73 0.1886
18 DRUG THERAPY 62 0.1829
19 X-RAY ABNORMAL 314 0.1754
20 RHEUMATIC FEVER 751 0.1683
21 ANTICOAGULANT THERAPY 47 0.1655
22 FACET JOINT SYNDROME 526 0.1614
23 BRONCHIAL HAEMORRHAGE 50 0.1603
24 DUODENAL ULCER PERFORATION 1122 0.1507
25 NASAL OEDEMA 264 0.1460
26 DISLOCATION OF VERTEBRA 331 0.1450
27 RHEUMATOID FACTOR POSITIVE 827 0.1430
28 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1018 0.1419
29 BRONCHIAL WALL THICKENING 99 0.1377
30 ENDOMETRIAL ABLATION 49 0.1373
31 NASAL TURBINATE HYPERTROPHY 51 0.1353
32 PORPHYRIA ACUTE 183 0.1275
33 RETINITIS 218 0.1261
34 PERIPHERAL VENOUS DISEASE 509 0.1245
35 C-REACTIVE PROTEIN ABNORMAL 763 0.1188
36 MUSCLE INJURY 966 0.1165
37 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 745 0.1146
38 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3354 0.1144
39 HELICOBACTER INFECTION 1144 0.1112
40 SEDATION COMPLICATION 282 0.1104
41 FOLLICULITIS 1080 0.1029
42 VITAL CAPACITY DECREASED 46 0.1027
43 RIGHT VENTRICULAR HYPERTROPHY 91 0.1008
44 MULTIPLE DRUG THERAPY 75 0.0995
45 PEMPHIGUS 1146 0.0916
46 HAND DEFORMITY 1170 0.0891
47 REVERSIBLE AIRWAYS OBSTRUCTION 42 0.0827
48 AUTOIMMUNE DISORDER 806 0.0826
49 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 45 0.0802
50 BRONCHIAL SECRETION RETENTION 101 0.0793
51 DRUG TOLERANCE DECREASED 212 0.0754
52 CREATININE RENAL CLEARANCE DECREASED 300 0.0749
53 BONE EROSION 265 0.0749
54 LIP DRY 658 0.0724
55 PERICARDITIS 1176 0.0699
56 CREATININE RENAL CLEARANCE INCREASED 52 0.0695
57 SCHIZOAFFECTIVE DISORDER 120 0.0672
58 MATERNAL EXPOSURE TIMING UNSPECIFIED 239 0.0636
59 BREAST CANCER STAGE III 404 0.0623
60 SYNOVITIS 1089 0.0603
61 BURSITIS 731 0.0602
62 PULMONARY FUNCTION TEST ABNORMAL 93 0.0597
63 DRUG EFFECT VARIABLE 67 0.0591
64 AORTIC VALVE STENOSIS 101 0.0566
65 RHONCHI 76 0.0550
66 ULCER HAEMORRHAGE 371 0.0548
67 GLOSSODYNIA 1146 0.0511
68 JOINT RANGE OF MOTION DECREASED 681 0.0507
69 GRIP STRENGTH DECREASED 440 0.0499
70 LIVE BIRTH 414 0.0494
71 IRRITABLE BOWEL SYNDROME 1047 0.0488
72 HYPERCHOLESTEROLAEMIA 455 0.0471
73 FIBROMYALGIA 1137 0.0467
74 SCIATICA 735 0.0461
75 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 42 0.0453
76 OBESITY 686 0.0430
77 WOUND INFECTION 457 0.0417
78 LOWER LIMB FRACTURE 792 0.0412
79 SERONEGATIVE ARTHRITIS 46 0.0401
80 WHEEZING 2345 0.0395
81 ADJUSTMENT DISORDER 51 0.0392
82 LIVER INJURY 951 0.0387
83 WOUND 1045 0.0373
84 BRONCHIAL OBSTRUCTION 52 0.0370
85 HYPERPHOSPHATAEMIA 77 0.0358
86 EYE INJURY 107 0.0352
87 BRONCHIAL DISORDER 53 0.0341
88 OESOPHAGEAL SPASM 62 0.0336
89 OEDEMA 1821 0.0335
90 OBSTRUCTION 134 0.0335
91 SYSTEMIC LUPUS ERYTHEMATOSUS 1179 0.0332
92 PULMONARY PAIN 96 0.0329
93 EXOSTOSIS 297 0.0325
94 LOWER RESPIRATORY TRACT INFECTION 1476 0.0324
95 DIASTOLIC DYSFUNCTION 100 0.0324
96 CHEST X-RAY ABNORMAL 99 0.0323
97 FORCED EXPIRATORY VOLUME DECREASED 91 0.0321
98 TYPE 2 DIABETES MELLITUS 1080 0.0320
99 IMPAIRED HEALING 1044 0.0318
100 WALKING AID USER 204 0.0309
101 PRESCRIBED OVERDOSE 595 0.0307
102 RALES 172 0.0296
103 TOTAL LUNG CAPACITY DECREASED 47 0.0294
104 CONTRAINDICATED PRODUCT ADMINISTERED 887 0.0293
105 PULMONARY FIBROSIS 558 0.0291
106 ASTHMA 3254 0.0288
107 BLOOD CALCIUM DECREASED 321 0.0285
108 ACCIDENTAL DEATH 52 0.0280
109 BRONCHIECTASIS 184 0.0273
110 BLOOD CHOLESTEROL INCREASED 1268 0.0272
111 OBSTRUCTIVE AIRWAYS DISORDER 295 0.0265
112 BLOOD PHOSPHORUS INCREASED 72 0.0263
113 LUNG OPACITY 69 0.0262
114 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 438 0.0258
115 PRE-EXISTING CONDITION IMPROVED 161 0.0258
116 PSORIATIC ARTHROPATHY 1009 0.0248
117 ONYCHOMADESIS 104 0.0248
118 LUPUS-LIKE SYNDROME 224 0.0247
119 ARTHROPATHY 1371 0.0246
120 FULL BLOOD COUNT ABNORMAL 260 0.0246
121 BREATH SOUNDS ABNORMAL 121 0.0245
122 NIGHT SWEATS 771 0.0239
123 GAIT INABILITY 795 0.0238
124 BLEPHAROSPASM 149 0.0236
125 BENIGN PROSTATIC HYPERPLASIA 122 0.0236
126 FOOT DEFORMITY 258 0.0233
127 ROAD TRAFFIC ACCIDENT 950 0.0227
128 MIGRAINE 2156 0.0226
129 RESPIRATORY TRACT INFECTION 584 0.0224
130 OSTEOARTHRITIS 950 0.0224
131 HIP ARTHROPLASTY 341 0.0222
132 ALCOHOL POISONING 59 0.0220
133 BRONCHITIS CHRONIC 53 0.0217
134 BLISTER 1203 0.0214
135 MOBILITY DECREASED 1495 0.0208
136 DISCOMFORT 1267 0.0207
137 THERAPEUTIC PRODUCT EFFECT VARIABLE 80 0.0206
138 BREAST CANCER STAGE II 171 0.0205
139 PREGNANCY 410 0.0205
140 JOINT DISLOCATION 214 0.0202
141 DEPRESSIVE SYMPTOM 71 0.0201
142 AORTIC STENOSIS 70 0.0201
143 ONYCHOMYCOSIS 88 0.0200
144 STOMATITIS 1212 0.0200
145 INFUSION RELATED REACTION 1324 0.0200
146 PRODUCT USE IN UNAPPROVED INDICATION 4938 0.0199
147 HYPERCAPNIA 60 0.0199
148 SINUS PAIN 46 0.0197
149 RED BLOOD CELL SEDIMENTATION RATE INCREASED 216 0.0195
150 SLEEP APNOEA SYNDROME 370 0.0194
151 ORTHOSTATIC HYPOTENSION 333 0.0191
152 INJURY 1344 0.0191
153 HEPATIC ENZYME INCREASED 1302 0.0191
154 IRON DEFICIENCY 84 0.0187
155 LUNG DISORDER 909 0.0185
156 LIVER DISORDER 819 0.0184
157 KNEE ARTHROPLASTY 384 0.0182
158 RENAL FUNCTION TEST ABNORMAL 84 0.0181
159 SPUTUM DISCOLOURED 171 0.0180
160 INTERVERTEBRAL DISC DEGENERATION 165 0.0178
161 EAR PAIN 340 0.0175
162 CHOLECYSTITIS CHRONIC 116 0.0173
163 RESPIRATORY DISORDER 513 0.0171
164 NAIL DISORDER 149 0.0170
165 EMPHYSEMA 171 0.0169
166 SINUSITIS 1726 0.0168
167 THERAPEUTIC PRODUCT EFFECT DECREASED 753 0.0168
168 PRESCRIBED UNDERDOSE 334 0.0167
169 RESPIRATORY ACIDOSIS 65 0.0165
170 MUSCULOSKELETAL PAIN 860 0.0164
171 HEPATIC CIRRHOSIS 305 0.0162
172 NORMAL NEWBORN 88 0.0162
173 DELIRIUM 560 0.0161
174 INFUSION SITE REACTION 48 0.0161
175 RHINITIS 129 0.0160
176 THERAPY NON-RESPONDER 716 0.0159
177 SEDATION 415 0.0158
178 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 269 0.0157
179 DRUG LEVEL INCREASED 257 0.0155
180 MIGRAINE WITH AURA 42 0.0154
181 SINUS TACHYCARDIA 217 0.0153
182 SWELLING 1428 0.0152
183 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 796 0.0152
184 SLEEP DISORDER 1062 0.0150
185 HYPOVENTILATION 49 0.0150
186 GRANULOMA 52 0.0150
187 OESOPHAGEAL PAIN 59 0.0149
188 PRODUCT LABEL CONFUSION 87 0.0149
189 HYPOPNOEA 51 0.0147
190 MUSCULOSKELETAL STIFFNESS 1274 0.0145
191 ILL-DEFINED DISORDER 878 0.0144
192 RESPIRATION ABNORMAL 99 0.0143
193 BACK INJURY 156 0.0143
194 SPONDYLITIS 52 0.0143
195 INFUSION SITE PRURITUS 45 0.0142
196 CONTUSION 1366 0.0142
197 BLOOD URIC ACID INCREASED 81 0.0140
198 INFUSION SITE HAEMORRHAGE 46 0.0140
199 SEASONAL ALLERGY 197 0.0139
200 APPETITE DISORDER 92 0.0139
201 THERAPEUTIC RESPONSE UNEXPECTED 620 0.0138
202 MATERNAL EXPOSURE DURING PREGNANCY 1224 0.0137
203 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 69 0.0136
204 DRY MOUTH 1093 0.0135
205 GASTROINTESTINAL DISORDER 1203 0.0134
206 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 645 0.0134
207 ULCER 213 0.0134
208 DRUG INTOLERANCE 1293 0.0134
209 SNORING 50 0.0132
210 DRUG TOLERANCE 66 0.0130
211 FINGER DEFORMITY 63 0.0130
212 EAR INFECTION 346 0.0130
213 FEELING JITTERY 245 0.0128
214 LEFT VENTRICULAR FAILURE 44 0.0128
215 MULTIPLE DRUG OVERDOSE 63 0.0127
216 HYPOPHOSPHATAEMIA 93 0.0126
217 TOXICITY TO VARIOUS AGENTS 2121 0.0126
218 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 894 0.0126
219 ABDOMINAL DISCOMFORT 2103 0.0125
220 PUSTULAR PSORIASIS 43 0.0125
221 DEPRESSED LEVEL OF CONSCIOUSNESS 494 0.0125
222 PARANASAL SINUS HYPERSECRETION 47 0.0123
223 OSTEOPOROSIS 506 0.0123
224 LIVER FUNCTION TEST INCREASED 264 0.0123
225 PRODUCTIVE COUGH 585 0.0122
226 INFLAMMATION 632 0.0122
227 GOUT 218 0.0121
228 CONGENITAL ANOMALY 94 0.0121
229 INFUSION SITE SWELLING 76 0.0121
230 GENERAL PHYSICAL HEALTH DETERIORATION 1397 0.0121
231 DRUG LEVEL ABOVE THERAPEUTIC 55 0.0120
232 LYMPHOEDEMA 83 0.0120
233 CHRONIC SINUSITIS 45 0.0120
234 CHEST PAIN 2215 0.0119
235 GASTRIC ULCER 227 0.0119
236 JOINT SWELLING 1433 0.0119
237 CARDIAC MURMUR 102 0.0118
238 BREAST MASS 79 0.0118
239 VENTRICULAR ARRHYTHMIA 43 0.0117
240 DISABILITY 232 0.0117
241 RHEUMATOID ARTHRITIS 1331 0.0117
242 MEDICATION ERROR 649 0.0117
243 VENTRICULAR FIBRILLATION 127 0.0114
244 C-REACTIVE PROTEIN INCREASED 413 0.0113
245 APPENDICITIS 106 0.0113
246 DRUG EFFECT LESS THAN EXPECTED 167 0.0113
247 STOMACH DISCOMFORT 58 0.0112
248 FOOD ALLERGY 86 0.0111
249 SPINAL FUSION SURGERY 45 0.0111
250 WEIGHT FLUCTUATION 116 0.0111
251 DRUG TOXICITY 151 0.0111
252 COGNITIVE DISORDER 516 0.0110
253 STATUS EPILEPTICUS 123 0.0109
254 DRUG SCREEN POSITIVE 86 0.0109
255 AMNESIA 707 0.0109
256 PARANASAL SINUS DISCOMFORT 41 0.0108
257 DYSPEPSIA 1061 0.0108
258 CONFUSIONAL STATE 1739 0.0107
259 RASH VESICULAR 52 0.0107
260 MUSCLE SPASTICITY 132 0.0107
261 EXPOSURE DURING PREGNANCY 662 0.0106
262 SPINAL OSTEOARTHRITIS 93 0.0106
263 SKIN ABRASION 50 0.0106
264 NEPHROGENIC ANAEMIA 49 0.0106
265 TROPONIN INCREASED 80 0.0105
266 PULMONARY CONGESTION 138 0.0105
267 TENSION HEADACHE 45 0.0105
268 BLOOD LACTIC ACID INCREASED 55 0.0104
269 TREATMENT FAILURE 859 0.0104
270 FLANK PAIN 97 0.0103
271 EXPIRED DRUG ADMINISTERED 51 0.0103
272 HYPOAESTHESIA 1538 0.0103
273 MATERNAL EXPOSURE BEFORE PREGNANCY 70 0.0102
274 AFFECTIVE DISORDER 80 0.0102
275 INFUSION SITE PAIN 131 0.0102
276 ABDOMINAL PAIN UPPER 2086 0.0101
277 INFUSION SITE ERYTHEMA 85 0.0101
278 MULTIPLE ALLERGIES 79 0.0101
279 INTENTIONAL PRODUCT USE ISSUE 882 0.0101
280 PRODUCT ADMINISTRATION INTERRUPTED 79 0.0101
281 BLOOD CALCIUM INCREASED 88 0.0100
282 GASTRIC ULCER HAEMORRHAGE 55 0.0099
283 SUPRAVENTRICULAR TACHYCARDIA 95 0.0099
284 DYSPNOEA EXERTIONAL 373 0.0099
285 PULMONARY FUNCTION TEST DECREASED 43 0.0098
286 FREQUENT BOWEL MOVEMENTS 265 0.0098
287 GASTROOESOPHAGEAL REFLUX DISEASE 787 0.0098
288 UPPER RESPIRATORY TRACT INFECTION 450 0.0097
289 PAROSMIA 73 0.0097
290 HYPERTENSION 2049 0.0097
291 HYPERLIPIDAEMIA 115 0.0096
292 JOINT STIFFNESS 252 0.0096
293 INTERVERTEBRAL DISC DISORDER 41 0.0096
294 SINUS DISORDER 190 0.0096
295 GESTATIONAL DIABETES 45 0.0094
296 DRUG ABUSER 58 0.0094
297 RHINITIS ALLERGIC 42 0.0094
298 PERIPHERAL SWELLING 1450 0.0094
299 NASOPHARYNGITIS 1729 0.0094
300 ARTERIOSCLEROSIS CORONARY ARTERY 62 0.0093
301 MENINGITIS ASEPTIC 42 0.0093
302 BRAIN OEDEMA 118 0.0093
303 SPINAL COLUMN STENOSIS 44 0.0093
304 MYASTHENIA GRAVIS 75 0.0093
305 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 63 0.0093
306 RECTAL HAEMORRHAGE 397 0.0092
307 HYPERSENSITIVITY 1713 0.0092
308 URTICARIA 1538 0.0092
309 CONCUSSION 71 0.0092
310 VITAMIN D DECREASED 78 0.0091
311 BLOOD COUNT ABNORMAL 138 0.0091
312 POST-TRAUMATIC STRESS DISORDER 61 0.0091
313 COELIAC DISEASE 89 0.0091
314 SOMNAMBULISM 59 0.0090
315 SINUS HEADACHE 53 0.0089
316 BODY TEMPERATURE INCREASED 182 0.0089
317 DRUG ABUSE 741 0.0089
318 HIATUS HERNIA 115 0.0089
319 INFECTION 1274 0.0088
320 HYPERVENTILATION 51 0.0088
321 HYPERTRANSAMINASAEMIA 61 0.0088
322 CORONARY ARTERY STENOSIS 44 0.0087
323 DYSPNOEA 4948 0.0087
324 BRONCHITIS 642 0.0087
325 GINGIVAL PAIN 69 0.0087
326 PRE-ECLAMPSIA 41 0.0086
327 PNEUMONIA 2783 0.0086
328 ALOPECIA 1677 0.0085
329 EXERCISE TOLERANCE DECREASED 49 0.0085
330 BLOOD IRON DECREASED 101 0.0085
331 ARTHRITIS 664 0.0084
332 BLADDER DISORDER 83 0.0084
333 DERMATITIS ALLERGIC 104 0.0083
334 OEDEMA PERIPHERAL 999 0.0082
335 WEIGHT INCREASED 1830 0.0082
336 INSOMNIA 2170 0.0081
337 MYOSITIS 73 0.0081
338 GLAUCOMA 156 0.0081
339 VOMITING 3797 0.0081
340 FEELING DRUNK 60 0.0081
341 ABDOMINAL TENDERNESS 40 0.0080
342 CARDIOMEGALY 99 0.0080
343 OVERWEIGHT 43 0.0080
344 LABORATORY TEST ABNORMAL 236 0.0080
345 BLOOD MAGNESIUM DECREASED 69 0.0080
346 PREMATURE LABOUR 45 0.0080
347 ANXIETY 2261 0.0079
348 PHOTOPHOBIA 149 0.0079
349 SKIN LACERATION 86 0.0079
350 VITAMIN D DEFICIENCY 77 0.0079
351 RESPIRATORY RATE INCREASED 70 0.0079
352 COMPLETED SUICIDE 656 0.0079
353 WHITE BLOOD CELL COUNT INCREASED 302 0.0079
354 GASTRIC HAEMORRHAGE 90 0.0078
355 CONCOMITANT DISEASE AGGRAVATED 48 0.0078
356 BALANCE DISORDER 671 0.0078
357 GASTROENTERITIS 113 0.0077
358 NASAL CONGESTION 454 0.0077
359 ACIDOSIS 59 0.0077
360 DERMATITIS CONTACT 88 0.0077
361 VENTRICULAR EXTRASYSTOLES 80 0.0077
362 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 422 0.0077
363 EOSINOPHIL COUNT INCREASED 64 0.0077
364 CHEST DISCOMFORT 785 0.0077
365 HYPOKALAEMIA 352 0.0076
366 CONDITION AGGRAVATED 2305 0.0076
367 OROPHARYNGEAL DISCOMFORT 68 0.0075
368 NEURALGIA 183 0.0075
369 INTERVERTEBRAL DISC PROTRUSION 164 0.0075
370 ADRENAL INSUFFICIENCY 91 0.0075
371 APNOEA 58 0.0074
372 RIB FRACTURE 153 0.0074
373 ARTERIOSCLEROSIS 70 0.0074
374 SCOLIOSIS 46 0.0074
375 BACTERIAL INFECTION 138 0.0074
376 NECK PAIN 413 0.0074
377 ORAL CANDIDIASIS 97 0.0074
378 MUSCULAR WEAKNESS 833 0.0073
379 DEPRESSION 1665 0.0073
380 CARDIOGENIC SHOCK 105 0.0073
381 TRICUSPID VALVE INCOMPETENCE 58 0.0073
382 END STAGE RENAL DISEASE 133 0.0073
383 CHOLELITHIASIS 239 0.0073
384 BRAIN INJURY 73 0.0073
385 HEADACHE 4564 0.0073
386 BACK DISORDER 118 0.0072
387 PARAESTHESIA 1141 0.0072
388 ACUTE RESPIRATORY FAILURE 139 0.0072
389 METABOLIC ACIDOSIS 231 0.0072
390 RENAL CYST 57 0.0072
391 POOR QUALITY SLEEP 154 0.0071
392 ATELECTASIS 69 0.0071
393 DRUG INTERACTION 1125 0.0071
394 INCORRECT DRUG ADMINISTRATION DURATION 198 0.0070
395 MEMORY IMPAIRMENT 963 0.0070
396 WRIST FRACTURE 84 0.0070
397 OVERDOSE 1509 0.0070
398 INTENTIONAL OVERDOSE 448 0.0070
399 BLOOD TEST ABNORMAL 98 0.0070
400 AFFECT LABILITY 67 0.0070
401 DECREASED INTEREST 41 0.0069
402 EXPIRED PRODUCT ADMINISTERED 231 0.0069
403 FACIAL PAIN 62 0.0069
404 ASPIRATION 76 0.0069
405 INTENTIONAL PRODUCT MISUSE 605 0.0069
406 TINNITUS 317 0.0069
407 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 61 0.0069
408 ELECTROCARDIOGRAM ABNORMAL 54 0.0069
409 SUBSTANCE ABUSE 56 0.0069
410 DENTAL CARIES 76 0.0069
411 RESPIRATORY DEPRESSION 84 0.0068
412 TASTE DISORDER 139 0.0068
413 GRAND MAL CONVULSION 63 0.0068
414 ANKLE FRACTURE 105 0.0068
415 PULMONARY MASS 101 0.0068
416 DECREASED APPETITE 1574 0.0068
417 OCULAR DISCOMFORT 76 0.0068
418 PSEUDOMONAS INFECTION 58 0.0068
419 MUSCLE SPASMS 1237 0.0067
420 CYANOSIS 106 0.0067
421 COUGH 1889 0.0067
422 ECCHYMOSIS 46 0.0067
423 PAIN 4106 0.0067
424 PELVIC FRACTURE 52 0.0067
425 BLOOD PRESSURE INADEQUATELY CONTROLLED 40 0.0066
426 BODY HEIGHT DECREASED 71 0.0066
427 UNDERDOSE 484 0.0066
428 PRODUCT USE ISSUE 1246 0.0066
429 COLITIS ULCERATIVE 296 0.0066
430 ELECTROCARDIOGRAM QT PROLONGED 238 0.0066
431 CYSTITIS 210 0.0066
432 NERVE INJURY 73 0.0066
433 TACHYCARDIA 582 0.0065
434 RESPIRATORY TRACT CONGESTION 104 0.0065
435 FEELING HOT 399 0.0065
436 PYREXIA 2242 0.0065
437 PANCREATITIS 342 0.0065
438 GASTRIC DISORDER 221 0.0064
439 MAJOR DEPRESSION 47 0.0064
440 JOINT INJURY 137 0.0064
441 ADVERSE DRUG REACTION 575 0.0064
442 CIRCULATORY COLLAPSE 109 0.0064
443 OXYGEN SATURATION DECREASED 359 0.0064
444 GALLBLADDER DISORDER 114 0.0064
445 MALAISE 2793 0.0064
446 DEPRESSED MOOD 336 0.0063
447 BIPOLAR DISORDER 69 0.0063
448 HEAD DISCOMFORT 112 0.0063
449 GAIT DISTURBANCE 1210 0.0063
450 HAEMOPTYSIS 176 0.0063
451 ABDOMINAL PAIN 1466 0.0063
452 IRON DEFICIENCY ANAEMIA 58 0.0063
453 MYOPATHY 54 0.0062
454 MIDDLE INSOMNIA 116 0.0062
455 POISONING 78 0.0062
456 HEPATOMEGALY 61 0.0062
457 BODY TEMPERATURE DECREASED 61 0.0062
458 VENTRICULAR TACHYCARDIA 102 0.0062
459 BRONCHOSPASM 88 0.0062
460 MYOCARDIAL ISCHAEMIA 70 0.0061
461 LIMB INJURY 167 0.0061
462 SINUS CONGESTION 83 0.0061
463 INITIAL INSOMNIA 63 0.0061
464 MUSCLE STRAIN 53 0.0061
465 SPINAL DISORDER 58 0.0061
466 BLOOD POTASSIUM DECREASED 184 0.0061
467 NEPHROPATHY 57 0.0061
468 IMMUNODEFICIENCY 91 0.0061
469 DIZZINESS 3043 0.0061
470 CHOKING 119 0.0061
471 EPILEPSY 186 0.0061
472 ADVERSE EVENT 559 0.0061
473 UNRESPONSIVE TO STIMULI 156 0.0060
474 MICTURITION URGENCY 69 0.0060
475 ACCIDENT 72 0.0060
476 MITRAL VALVE INCOMPETENCE 68 0.0060
477 ARTHRALGIA 2498 0.0060
478 GENERAL SYMPTOM 45 0.0060
479 PALPITATIONS 702 0.0060
480 TOOTH FRACTURE 66 0.0060
481 SENSORY LOSS 48 0.0060
482 TOXIC EPIDERMAL NECROLYSIS 90 0.0059
483 ATRIAL FIBRILLATION 576 0.0059
484 DIVERTICULUM 42 0.0059
485 FOOT FRACTURE 112 0.0059
486 TRANSIENT ISCHAEMIC ATTACK 199 0.0059
487 HEART RATE INCREASED 583 0.0059
488 PNEUMONIA BACTERIAL 54 0.0059
489 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 42 0.0059
490 THERAPEUTIC RESPONSE DECREASED 355 0.0058
491 TENDERNESS 61 0.0058
492 HEPATIC STEATOSIS 109 0.0058
493 PANIC ATTACK 213 0.0058
494 RESPIRATORY ARREST 161 0.0058
495 CARDIO-RESPIRATORY ARREST 244 0.0058
496 DRUG-INDUCED LIVER INJURY 183 0.0058
497 BLOOD PRESSURE DIASTOLIC DECREASED 43 0.0058
498 ACCIDENTAL OVERDOSE 213 0.0058
499 IMPAIRED DRIVING ABILITY 66 0.0058
500 MENTAL STATUS CHANGES 161 0.0058
501 TOOTH ABSCESS 59 0.0058
502 LUNG INFILTRATION 51 0.0058
503 ANOREXIA 74 0.0057
504 FLUID RETENTION 292 0.0057
505 PULMONARY OEDEMA 257 0.0057
506 HYPOXIA 202 0.0057
507 PAIN IN EXTREMITY 1690 0.0057
508 SUICIDE ATTEMPT 347 0.0057
509 OVARIAN CYST 57 0.0057
510 PAIN IN JAW 161 0.0057
511 ECONOMIC PROBLEM 86 0.0057
512 ANAL INCONTINENCE 51 0.0057
513 HAEMATEMESIS 143 0.0056
514 NAUSEA 4462 0.0056
515 DRUG INEFFECTIVE 7405 0.0056
516 MUSCLE TIGHTNESS 91 0.0056
517 ATRIAL SEPTAL DEFECT 47 0.0056
518 RESTLESS LEGS SYNDROME 102 0.0056
519 MOTOR DYSFUNCTION 57 0.0056
520 HEREDITARY ANGIOEDEMA 60 0.0056
521 GASTRITIS 147 0.0056
522 RESPIRATORY FAILURE 407 0.0056
523 ASTHENIA 2097 0.0056
524 CONSTIPATION 1216 0.0056
525 URINARY INCONTINENCE 165 0.0056
526 CARDIOMYOPATHY 82 0.0055
527 HEMIPLEGIA 46 0.0055
528 COAGULOPATHY 92 0.0055
529 ANGINA PECTORIS 158 0.0055
530 WEIGHT DECREASED 1535 0.0055
531 HEMIPARESIS 93 0.0055
532 PHARYNGITIS 68 0.0055
533 DYSARTHRIA 206 0.0055
534 NEPHROLITHIASIS 251 0.0055
535 ARTERIAL OCCLUSIVE DISEASE 43 0.0055
536 FALL 1809 0.0054
537 IMPAIRED QUALITY OF LIFE 78 0.0054
538 NERVOUSNESS 283 0.0054
539 INTENTIONAL DRUG MISUSE 113 0.0054
540 INCONTINENCE 57 0.0054
541 SOMNOLENCE 1085 0.0054
542 TREMOR 893 0.0054
543 GENERALISED TONIC-CLONIC SEIZURE 89 0.0054
544 ROTATOR CUFF SYNDROME 69 0.0054
545 CONVULSION 302 0.0053
546 EUPHORIC MOOD 54 0.0053
547 PARAESTHESIA ORAL 76 0.0053
548 BACK PAIN 1221 0.0053
549 HEAD INJURY 166 0.0052
550 INSURANCE ISSUE 80 0.0052
551 UPPER-AIRWAY COUGH SYNDROME 43 0.0052
552 RESTLESSNESS 191 0.0052
553 INCREASED TENDENCY TO BRUISE 48 0.0052
554 LOSS OF CONSCIOUSNESS 668 0.0052
555 VERTIGO 317 0.0052
556 RHINORRHOEA 335 0.0052
557 PNEUMOTHORAX 82 0.0052
558 ASCITES 152 0.0052
559 POST PROCEDURAL INFECTION 42 0.0052
560 RETCHING 110 0.0052
561 GASTROENTERITIS VIRAL 93 0.0051
562 DRUG ADMINISTRATION ERROR 158 0.0051
563 HYPOTHYROIDISM 164 0.0051
564 IMPAIRED GASTRIC EMPTYING 70 0.0051
565 SNEEZING 115 0.0051
566 THYROID DISORDER 79 0.0051
567 FEELING ABNORMAL 1220 0.0051
568 PRODUCT QUALITY ISSUE 691 0.0051
569 FATIGUE 3961 0.0051
570 HAEMORRHOIDS 99 0.0051
571 CARPAL TUNNEL SYNDROME 71 0.0051
572 ENCEPHALOPATHY 124 0.0050
573 ABDOMINAL DISTENSION 527 0.0050
574 SENSORY DISTURBANCE 81 0.0050
575 HYPERHIDROSIS 649 0.0050
576 TOOTHACHE 91 0.0050
577 ASPHYXIA 41 0.0050
578 BEDRIDDEN 66 0.0050
579 CATARACT 299 0.0050
580 HYPOTENSION 1007 0.0050
581 VIRAL INFECTION 167 0.0050
582 HEART RATE IRREGULAR 113 0.0050
583 HYPOAESTHESIA ORAL 75 0.0050
584 CANDIDA INFECTION 84 0.0050
585 SCAR 85 0.0050
586 SPINAL COMPRESSION FRACTURE 41 0.0050
587 THROAT TIGHTNESS 134 0.0049
588 SPLENOMEGALY 58 0.0049
589 ACTIVITIES OF DAILY LIVING IMPAIRED 98 0.0049
590 HAEMATOCRIT DECREASED 98 0.0049
591 MASS 69 0.0049
592 APATHY 72 0.0049
593 DYSSTASIA 144 0.0049
594 BLOOD PRESSURE SYSTOLIC INCREASED 96 0.0049
595 DIABETES MELLITUS 375 0.0049
596 EOSINOPHILIA 86 0.0049
597 CELLULITIS 247 0.0049
598 PHARMACEUTICAL PRODUCT COMPLAINT 127 0.0049
599 AGITATION 359 0.0049
600 BLOOD PRESSURE ABNORMAL 97 0.0049
601 LEUKOCYTOSIS 88 0.0049
602 HERNIA 94 0.0049
603 LIGAMENT SPRAIN 48 0.0048
604 BLOOD PRESSURE INCREASED 742 0.0048
605 MUSCULOSKELETAL CHEST PAIN 75 0.0048
606 DISORIENTATION 192 0.0048
607 DECREASED ACTIVITY 52 0.0048
608 DRUG EFFECT INCOMPLETE 175 0.0048
609 CHOLECYSTECTOMY 55 0.0048
610 OSTEOPENIA 73 0.0048
611 DYSURIA 177 0.0048
612 PERIPHERAL COLDNESS 66 0.0048
613 ATAXIA 57 0.0048
614 URINARY RETENTION 160 0.0048
615 PULMONARY EMBOLISM 454 0.0048
616 RHABDOMYOLYSIS 199 0.0048
617 HYPOACUSIS 205 0.0048
618 MYDRIASIS 61 0.0048
619 TUBULOINTERSTITIAL NEPHRITIS 89 0.0047
620 NIGHTMARE 164 0.0047
621 HUNGER 66 0.0047
622 RASH 2065 0.0047
623 PRURITUS 1816 0.0047
624 HYPERSOMNIA 135 0.0047
625 LUNG INFECTION 73 0.0047
626 PHARYNGEAL OEDEMA 72 0.0047
627 TEMPERATURE INTOLERANCE 48 0.0046
628 STEVENS-JOHNSON SYNDROME 103 0.0046
629 IMPAIRED WORK ABILITY 99 0.0046
630 CHOLECYSTITIS 55 0.0046
631 NOCTURIA 56 0.0046
632 PULMONARY HYPERTENSION 96 0.0046
633 INFLUENZA 513 0.0046
634 MENTAL IMPAIRMENT 111 0.0046
635 TACHYPNOEA 62 0.0046
636 RASH PRURITIC 247 0.0046
637 LIMB DISCOMFORT 141 0.0046
638 CAESAREAN SECTION 53 0.0045
639 NERVE COMPRESSION 42 0.0045
640 GASTROINTESTINAL PAIN 50 0.0045
641 ACUTE HEPATIC FAILURE 62 0.0045
642 DYSPHONIA 265 0.0045
643 RENAL PAIN 48 0.0045
644 DRY THROAT 46 0.0045
645 CORONARY ARTERY DISEASE 137 0.0045
646 OROPHARYNGEAL PAIN 418 0.0045
647 CHRONIC KIDNEY DISEASE 343 0.0045
648 CARDIAC FAILURE CONGESTIVE 362 0.0045
649 HYPERGLYCAEMIA 164 0.0045
650 DEFORMITY 42 0.0045
651 THIRST 80 0.0045
652 UPPER GASTROINTESTINAL HAEMORRHAGE 75 0.0045
653 BLOOD PRESSURE FLUCTUATION 107 0.0045
654 HYPONATRAEMIA 251 0.0045
655 PHARYNGITIS STREPTOCOCCAL 48 0.0044
656 SEROTONIN SYNDROME 85 0.0044
657 DRUG DEPENDENCE 711 0.0044
658 DIARRHOEA 2841 0.0044
659 RESPIRATORY DISTRESS 121 0.0044
660 FEELING COLD 122 0.0044
661 FAECES DISCOLOURED 95 0.0044
662 MUSCLE TWITCHING 101 0.0044
663 EJECTION FRACTION DECREASED 68 0.0044
664 CARDIAC ARREST 361 0.0044
665 BLOOD URINE PRESENT 83 0.0044
666 ARRHYTHMIA 207 0.0044
667 APHONIA 61 0.0044
668 BLOOD UREA INCREASED 73 0.0044
669 LACERATION 41 0.0044
670 PREMATURE BABY 131 0.0043
671 HEPATITIS 111 0.0043
672 DIZZINESS POSTURAL 42 0.0043
673 SWOLLEN TONGUE 135 0.0043
674 MENTAL DISORDER 188 0.0043
675 MULTIPLE ORGAN DYSFUNCTION SYNDROME 122 0.0043
676 THROAT IRRITATION 193 0.0043
677 HERPES ZOSTER 247 0.0043
678 PLATELET COUNT INCREASED 56 0.0043
679 DEEP VEIN THROMBOSIS 279 0.0043
680 BONE DISORDER 78 0.0043
681 ACUTE MYOCARDIAL INFARCTION 126 0.0043
682 HYPOKINESIA 62 0.0043
683 DYSPHAGIA 404 0.0043
684 TOOTH INFECTION 56 0.0042
685 REBOUND EFFECT 48 0.0042
686 DIPLOPIA 110 0.0042
687 LETHARGY 243 0.0042
688 ADVERSE REACTION 56 0.0042
689 VISUAL IMPAIRMENT 522 0.0042
690 APHASIA 127 0.0042
691 PHARYNGEAL SWELLING 41 0.0042
692 BONE PAIN 243 0.0041
693 HYPERCALCAEMIA 51 0.0041
694 VISION BLURRED 567 0.0041
695 PRODUCT PHYSICAL ISSUE 83 0.0041
696 DIVERTICULITIS 114 0.0041
697 HAEMOGLOBIN DECREASED 422 0.0041
698 RENAL FAILURE ACUTE 174 0.0041
699 IMMUNE SYSTEM DISORDER 54 0.0041
700 DEHYDRATION 543 0.0041
701 MUSCULOSKELETAL DISCOMFORT 70 0.0041
702 TENDON RUPTURE 50 0.0040
703 URINARY TRACT INFECTION 689 0.0040
704 HALLUCINATION 304 0.0040
705 BLOOD SODIUM DECREASED 76 0.0040
706 SPEECH DISORDER 211 0.0040
707 HALLUCINATION, VISUAL 85 0.0040
708 SUBARACHNOID HAEMORRHAGE 41 0.0040
709 CHILLS 471 0.0040
710 ORAL HERPES 78 0.0040
711 ANHEDONIA 105 0.0040
712 RED BLOOD CELL COUNT DECREASED 114 0.0040
713 SPINAL OPERATION 49 0.0040
714 NERVOUS SYSTEM DISORDER 124 0.0040
715 PNEUMONIA ASPIRATION 99 0.0040
716 POST PROCEDURAL COMPLICATION 76 0.0040
717 SUICIDAL IDEATION 361 0.0039
718 PRODUCT USE COMPLAINT 62 0.0039
719 KIDNEY INFECTION 77 0.0039
720 CHROMATURIA 88 0.0039
721 SPINAL FRACTURE 78 0.0039
722 BLOOD CREATINE PHOSPHOKINASE INCREASED 112 0.0039
723 PRURITUS GENERALISED 84 0.0039
724 GENERALISED OEDEMA 48 0.0039
725 COMA 184 0.0039
726 LIVER FUNCTION TEST ABNORMAL 112 0.0038
727 BLOOD PRESSURE DECREASED 255 0.0038
728 IRRITABILITY 230 0.0038
729 SMALL INTESTINAL OBSTRUCTION 47 0.0038
730 ANGER 129 0.0038
731 ORAL DISCOMFORT 53 0.0038
732 THROMBOSIS 305 0.0038
733 PRODUCT COMPLAINT 96 0.0038
734 SYNCOPE 379 0.0038
735 ILEUS 47 0.0038
736 ILLNESS 389 0.0038
737 HEPATOTOXICITY 84 0.0038
738 MOVEMENT DISORDER 121 0.0038
739 HEART RATE DECREASED 132 0.0038
740 MALNUTRITION 42 0.0038
741 SKIN INFECTION 42 0.0037
742 DYSGEUSIA 278 0.0037
743 POLLAKIURIA 156 0.0037
744 DIABETES MELLITUS INADEQUATE CONTROL 66 0.0037
745 QUALITY OF LIFE DECREASED 50 0.0037
746 FOETAL EXPOSURE DURING PREGNANCY 302 0.0037
747 INCORRECT DOSE ADMINISTERED 848 0.0037
748 SKIN HAEMORRHAGE 55 0.0037
749 DISTURBANCE IN ATTENTION 200 0.0037
750 INFLUENZA LIKE ILLNESS 305 0.0037
751 SWELLING FACE 241 0.0037
752 NO THERAPEUTIC RESPONSE 45 0.0037
753 COLD SWEAT 65 0.0037
754 CRYING 134 0.0037
755 DEMENTIA 103 0.0037
756 SKIN DISCOLOURATION 169 0.0037
757 LOCAL SWELLING 64 0.0037
758 HYPOMAGNESAEMIA 51 0.0037
759 HYPERTHYROIDISM 53 0.0037
760 COORDINATION ABNORMAL 51 0.0037
761 SEIZURE 422 0.0036
762 HAEMATURIA 125 0.0036
763 FEEDING DISORDER 74 0.0036
764 FEAR 98 0.0036
765 PROCEDURAL PAIN 101 0.0036
766 CENTRAL NERVOUS SYSTEM LESION 50 0.0036
767 LOCALISED INFECTION 88 0.0036
768 EPISTAXIS 272 0.0036
769 ASPARTATE AMINOTRANSFERASE INCREASED 193 0.0036
770 EMOTIONAL DISORDER 112 0.0036
771 HAEMATOCHEZIA 200 0.0036
772 ABNORMAL DREAMS 100 0.0036
773 TREATMENT NONCOMPLIANCE 198 0.0036
774 ACUTE RESPIRATORY DISTRESS SYNDROME 64 0.0036
775 ORAL PAIN 81 0.0036
776 TENDONITIS 56 0.0036
777 HYPOGLYCAEMIA 175 0.0036
778 MACULAR DEGENERATION 43 0.0036
779 THINKING ABNORMAL 67 0.0036
780 SPINAL PAIN 42 0.0036
781 BLOOD ALKALINE PHOSPHATASE INCREASED 89 0.0036
782 UNEVALUABLE EVENT 271 0.0036
783 EXTRA DOSE ADMINISTERED 145 0.0036
784 LYMPHOCYTE COUNT DECREASED 63 0.0036
785 DRUG EXPOSURE DURING PREGNANCY 121 0.0036
786 HAEMATOMA 92 0.0035
787 CYST 44 0.0035
788 FUNGAL INFECTION 118 0.0035
789 ELECTROLYTE IMBALANCE 41 0.0035
790 WRONG TECHNIQUE IN DRUG USAGE PROCESS 128 0.0035
791 WITHDRAWAL SYNDROME 147 0.0035
792 EYE PRURITUS 117 0.0035
793 DISSEMINATED INTRAVASCULAR COAGULATION 49 0.0035
794 ABDOMINAL PAIN LOWER 88 0.0035
795 DEAFNESS 91 0.0035
796 BURNING SENSATION 244 0.0035
797 SKIN DISORDER 116 0.0035
798 EYE PAIN 196 0.0035
799 MANIA 57 0.0035
800 MULTIPLE SCLEROSIS 165 0.0034
801 CONJUNCTIVITIS 64 0.0034
802 NODULE 45 0.0034
803 SHOCK 79 0.0034
804 SEPSIS 383 0.0034
805 ANAEMIA 654 0.0034
806 CORONARY ARTERY OCCLUSION 47 0.0034
807 TOOTH DISORDER 76 0.0034
808 PRESYNCOPE 83 0.0034
809 PELVIC PAIN 62 0.0034
810 PLEURAL EFFUSION 207 0.0034
811 PRODUCT TASTE ABNORMAL 46 0.0034
812 DYSKINESIA 138 0.0034
813 PALLOR 92 0.0034
814 SCHIZOPHRENIA 41 0.0034
815 SECRETION DISCHARGE 42 0.0034
816 OFF LABEL USE 2929 0.0033
817 THERAPY PARTIAL RESPONDER 52 0.0033
818 HOT FLUSH 251 0.0033
819 INCORRECT PRODUCT ADMINISTRATION DURATION 72 0.0033
820 DRUG EFFECT DECREASED 179 0.0033
821 ABASIA 82 0.0033
822 PRODUCT ADMINISTRATION ERROR 67 0.0033
823 EYE SWELLING 122 0.0033
824 RENAL FAILURE 435 0.0033
825 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 233 0.0033
826 COLITIS 124 0.0033
827 LIP SWELLING 108 0.0032
828 MYALGIA 551 0.0032
829 ALTERED STATE OF CONSCIOUSNESS 70 0.0032
830 STAPHYLOCOCCAL INFECTION 106 0.0032
831 DYSTONIA 62 0.0032
832 GASTROINTESTINAL HAEMORRHAGE 266 0.0032
833 SKIN ULCER 82 0.0032
834 BLOOD CREATININE INCREASED 207 0.0032
835 MULTIPLE SCLEROSIS RELAPSE 217 0.0032
836 MENORRHAGIA 62 0.0032
837 TRANSAMINASES INCREASED 70 0.0031
838 EYE HAEMORRHAGE 42 0.0031
839 LACRIMATION INCREASED 95 0.0031
840 PARANOIA 54 0.0031
841 DISEASE RECURRENCE 149 0.0031
842 CARDIAC FAILURE 251 0.0031
843 NEUROPATHY PERIPHERAL 297 0.0031
844 HYPOCALCAEMIA 59 0.0031
845 UPPER LIMB FRACTURE 62 0.0031
846 CEREBROVASCULAR ACCIDENT 525 0.0031
847 DRY EYE 154 0.0031
848 HEPATIC FAILURE 93 0.0031
849 PSYCHOTIC DISORDER 91 0.0031
850 PERICARDIAL EFFUSION 71 0.0031
851 SURGERY 180 0.0031
852 HAIR TEXTURE ABNORMAL 41 0.0031
853 FLUSHING 309 0.0030
854 FEMUR FRACTURE 94 0.0030
855 INTERNATIONAL NORMALISED RATIO INCREASED 86 0.0030
856 THERAPEUTIC RESPONSE SHORTENED 100 0.0030
857 MOOD SWINGS 96 0.0030
858 BRADYCARDIA 159 0.0030
859 FLATULENCE 170 0.0030
860 ANAPHYLACTIC REACTION 164 0.0030
861 EATING DISORDER 63 0.0030
862 PNEUMONITIS 79 0.0029
863 LEUKOPENIA 145 0.0029
864 PULMONARY ARTERIAL HYPERTENSION 42 0.0029
865 DELUSION 45 0.0029
866 ABORTION SPONTANEOUS 116 0.0029
867 MULTI-ORGAN FAILURE 50 0.0029
868 PSYCHOMOTOR HYPERACTIVITY 48 0.0029
869 MYOCARDIAL INFARCTION 504 0.0029
870 PREMATURE DELIVERY 46 0.0029
871 OCULAR HYPERAEMIA 137 0.0029
872 THROMBOCYTOPENIA 322 0.0029
873 HAEMORRHAGE INTRACRANIAL 43 0.0029
874 INJECTION SITE REACTION 197 0.0029
875 MOOD ALTERED 78 0.0029
876 ABNORMAL BEHAVIOUR 113 0.0028
877 PHOTOSENSITIVITY REACTION 47 0.0028
878 INTENTIONAL DOSE OMISSION 81 0.0028
879 MUSCULOSKELETAL DISORDER 54 0.0028
880 CARDIAC DISORDER 265 0.0028
881 ACUTE KIDNEY INJURY 433 0.0028
882 ECZEMA 148 0.0028
883 LYMPHADENOPATHY 100 0.0028
884 MELAENA 62 0.0028
885 RENAL DISORDER 131 0.0028
886 HIP FRACTURE 90 0.0028
887 HALLUCINATION, AUDITORY 44 0.0028
888 EYE DISORDER 91 0.0028
889 OSTEOMYELITIS 50 0.0028
890 MOUTH ULCERATION 58 0.0027
891 GAMMA-GLUTAMYLTRANSFERASE INCREASED 61 0.0027
892 VISUAL ACUITY REDUCED 91 0.0027
893 ERUCTATION 53 0.0027
894 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 493 0.0027
895 ALANINE AMINOTRANSFERASE INCREASED 166 0.0027
896 HYPOPHAGIA 69 0.0027
897 SKIN LESION 74 0.0027
898 METASTASES TO BONE 44 0.0027
899 HAEMORRHAGE 278 0.0027
900 INTESTINAL OBSTRUCTION 100 0.0027
901 PSORIASIS 343 0.0026
902 AGGRESSION 131 0.0026
903 INCREASED APPETITE 50 0.0026
904 PRODUCT DOSE OMISSION IN ERROR 74 0.0026
905 VAGINAL HAEMORRHAGE 113 0.0026
906 ANAPHYLACTIC SHOCK 67 0.0026
907 COVID-19 455 0.0026
908 CYTOKINE RELEASE SYNDROME 52 0.0026
909 BLOOD POTASSIUM INCREASED 42 0.0026
910 PANCREATITIS ACUTE 58 0.0026
911 BLINDNESS 105 0.0026
912 ABSCESS 41 0.0026
913 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 519 0.0026
914 CEREBRAL INFARCTION 62 0.0025
915 AGEUSIA 63 0.0025
916 EMOTIONAL DISTRESS 302 0.0025
917 HEPATIC FUNCTION ABNORMAL 93 0.0025
918 JAUNDICE 66 0.0025
919 RASH MACULAR 85 0.0024
920 CEREBRAL HAEMORRHAGE 86 0.0024
921 PRODUCT DOSE OMISSION ISSUE 705 0.0024
922 TOOTH LOSS 49 0.0024
923 FRACTURE 44 0.0023
924 CARDIOVASCULAR DISORDER 59 0.0023
925 RENAL IMPAIRMENT 193 0.0023
926 BLOOD GLUCOSE DECREASED 110 0.0023
927 INJECTION SITE URTICARIA 56 0.0023
928 HYPERKALAEMIA 80 0.0023
929 RASH PAPULAR 51 0.0023
930 HOSPITALISATION 347 0.0023
931 RENAL INJURY 67 0.0023
932 WHITE BLOOD CELL COUNT DECREASED 243 0.0022
933 PRODUCT SUBSTITUTION ISSUE 129 0.0022
934 PLATELET COUNT DECREASED 237 0.0022
935 BONE DENSITY DECREASED 69 0.0022
936 CLOSTRIDIUM DIFFICILE INFECTION 48 0.0022
937 INTERSTITIAL LUNG DISEASE 103 0.0021
938 DRUG DOSE OMISSION 348 0.0021
939 INJECTION SITE BRUISING 167 0.0021
940 ERYTHEMA 430 0.0021
941 NEUTROPHIL COUNT DECREASED 85 0.0021
942 PRODUCT DOSE OMISSION 136 0.0021
943 TARDIVE DYSKINESIA 58 0.0021
944 RASH GENERALISED 53 0.0020
945 MUCOSAL INFLAMMATION 53 0.0020
946 PRODUCT AVAILABILITY ISSUE 46 0.0020
947 DRUG WITHDRAWAL SYNDROME 177 0.0020
948 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 68 0.0020
949 THERAPY CESSATION 103 0.0020
950 FEBRILE NEUTROPENIA 133 0.0020
951 RASH ERYTHEMATOUS 95 0.0020
952 INJECTION SITE PRURITUS 133 0.0020
953 LACTIC ACIDOSIS 63 0.0019
954 INJECTION SITE PAIN 591 0.0019
955 INJECTION SITE RASH 58 0.0019
956 DEPENDENCE 100 0.0018
957 BREAST CANCER 170 0.0018
958 DERMATITIS ATOPIC 96 0.0018
959 ANGIOEDEMA 80 0.0018
960 SKIN EXFOLIATION 147 0.0017
961 BLOOD BILIRUBIN INCREASED 47 0.0017
962 DEVICE DISLOCATION 75 0.0017
963 BLOOD GLUCOSE INCREASED 325 0.0017
964 INJECTION SITE SWELLING 132 0.0017
965 EYE IRRITATION 99 0.0017
966 PAIN OF SKIN 46 0.0017
967 SEPTIC SHOCK 73 0.0017
968 INJECTION SITE MASS 61 0.0016
969 INJECTION SITE HAEMORRHAGE 129 0.0016
970 BREAST CANCER FEMALE 43 0.0016
971 INJECTION SITE ERYTHEMA 198 0.0016
972 LUNG NEOPLASM MALIGNANT 64 0.0016
973 OSTEONECROSIS 50 0.0015
974 THERAPY INTERRUPTED 108 0.0015
975 INCORRECT ROUTE OF DRUG ADMINISTRATION 52 0.0015
976 NEOPLASM MALIGNANT 97 0.0015
977 PRODUCT ADHESION ISSUE 51 0.0014
978 DEATH 1220 0.0014
979 ACNE 106 0.0014
980 DRY SKIN 182 0.0014
981 NEUTROPENIA 184 0.0014
982 DEVICE MALFUNCTION 95 0.0014
983 PANCYTOPENIA 74 0.0013
984 MALIGNANT NEOPLASM PROGRESSION 133 0.0013
985 DISEASE PROGRESSION 145 0.0012
986 DEVICE ISSUE 98 0.0011
987 ACCIDENTAL EXPOSURE TO PRODUCT 112 0.0011
988 PRODUCT STORAGE ERROR 94 0.0011
989 SKIN IRRITATION 48 0.0010
990 SKIN BURNING SENSATION 73 0.0010
991 DEVICE BREAKAGE 41 0.0010
992 DEVICE DIFFICULT TO USE 66 0.0010
993 NO ADVERSE EVENT 149 0.0008